Literature DB >> 17602286

Multifaceted roles of integrins in breast cancer metastasis.

Donald E White1, William J Muller.   

Abstract

Malignant breast cancer can be a debilitating disease due to metastasis to tissues such as brain or bone. The metastatic process involves the invasion of tumor cells into the adjacent tissue, followed by systemic dissemination and colonization of secondary organs. These processes require interactions between tumor cells and a changing microenvironment, which drive cell proliferation, migration, invasion and colonization, as well as promoting cell survival. The integrin family of cell adhesion receptors has been shown to play a critical role in all of these processes, consistent with their extracellular matrix binding properties. Experiments in cultured epithelial cells and in vivo models have demonstrated that integrins can promote various stages of metastasis by modulating the effects of growth factor receptors, extracellular proteases and chemotactic molecules. Integrins may therefore play a pivotal role in multiple mechanisms of metastasis. As a result, they represent promising targets for effective treatment of metastatic breast cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17602286     DOI: 10.1007/s10911-007-9045-5

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  64 in total

Review 1.  The urokinase receptor: involvement in cell surface proteolysis and cancer invasion.

Authors:  V Ellis; C Pyke; J Eriksen; H Solberg; K Danø
Journal:  Ann N Y Acad Sci       Date:  1992-12-04       Impact factor: 5.691

2.  beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium.

Authors:  Valerie M Weaver; Sophie Lelièvre; Johnathon N Lakins; Micah A Chrenek; Jonathan C R Jones; Filippo Giancotti; Zena Werb; Mina J Bissell
Journal:  Cancer Cell       Date:  2002-09       Impact factor: 31.743

3.  Coexpression of integrin alpha(v)beta3 and matrix metalloproteinase-2 (MMP-2) coincides with MMP-2 activation: correlation with melanoma progression.

Authors:  U B Hofmann; J R Westphal; E T Waas; J C Becker; D J Ruiter; G N van Muijen
Journal:  J Invest Dermatol       Date:  2000-10       Impact factor: 8.551

4.  Dormancy of mammary carcinoma after mastectomy.

Authors:  T G Karrison; D J Ferguson; P Meier
Journal:  J Natl Cancer Inst       Date:  1999-01-06       Impact factor: 13.506

Review 5.  Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.

Authors:  D Hanahan; J Folkman
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

6.  Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells.

Authors:  A B Tuck; D M Arsenault; F P O'Malley; C Hota; M C Ling; S M Wilson; A F Chambers
Journal:  Oncogene       Date:  1999-07-22       Impact factor: 9.867

7.  The problem of cancer dormancy: understanding the basic mechanisms and identifying therapeutic opportunities.

Authors:  Julio A Aguirre-Ghiso
Journal:  Cell Cycle       Date:  2006-08-15       Impact factor: 4.534

Review 8.  Critical determinants of metastasis.

Authors:  Isaiah J Fidler
Journal:  Semin Cancer Biol       Date:  2002-04       Impact factor: 15.707

9.  Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo.

Authors:  U B Hofmann; J R Westphal; A A Van Kraats; D J Ruiter; G N Van Muijen
Journal:  Int J Cancer       Date:  2000-07-01       Impact factor: 7.396

Review 10.  Dissemination and growth of cancer cells in metastatic sites.

Authors:  Ann F Chambers; Alan C Groom; Ian C MacDonald
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

View more
  37 in total

1.  Oral delivery of PND-1186 FAK inhibitor decreases tumor growth and spontaneous breast to lung metastasis in pre-clinical models.

Authors:  Colin Walsh; Isabelle Tanjoni; Sean Uryu; Alok Tomar; Ju-Ock Nam; Hong Luo; Angelica Phillips; Neela Patel; Cheni Kwok; Gerald McMahon; Dwayne G Stupack; David D Schlaepfer
Journal:  Cancer Biol Ther       Date:  2010-05-15       Impact factor: 4.742

Review 2.  Divide or Conquer: Cell Cycle Regulation of Invasive Behavior.

Authors:  Abraham Q Kohrman; David Q Matus
Journal:  Trends Cell Biol       Date:  2016-09-12       Impact factor: 20.808

3.  In vivo identification of regulators of cell invasion across basement membranes.

Authors:  David Q Matus; Xiao-Yan Li; Sarah Durbin; Daniel Agarwal; Qiuyi Chi; Stephen J Weiss; David R Sherwood
Journal:  Sci Signal       Date:  2010-05-04       Impact factor: 8.192

4.  Role of integrins in regulating proteases to mediate extracellular matrix remodeling.

Authors:  Jiao Yue; Kun Zhang; Jianfeng Chen
Journal:  Cancer Microenviron       Date:  2012-03-22

5.  The α₂β₁ integrin is a metastasis suppressor in mouse models and human cancer.

Authors:  Norma E Ramirez; Zhonghua Zhang; Aasakiran Madamanchi; Kelli L Boyd; Lynda D O'Rear; Abudi Nashabi; Zhengzi Li; William D Dupont; Andries Zijlstra; Mary M Zutter
Journal:  J Clin Invest       Date:  2010-12-06       Impact factor: 14.808

Review 6.  FERM control of FAK function: implications for cancer therapy.

Authors:  Ssang-Taek Lim; David Mikolon; Dwayne G Stupack; David D Schlaepfer
Journal:  Cell Cycle       Date:  2008-05-29       Impact factor: 4.534

7.  Intracellular targets of RGDS peptide in melanoma cells.

Authors:  Maria Simona Aguzzi; Paola Fortugno; Claudia Giampietri; Gianluca Ragone; Maurizio C Capogrossi; Antonio Facchiano
Journal:  Mol Cancer       Date:  2010-04-22       Impact factor: 27.401

8.  Targeting of integrin beta1 and kinesin 2alpha by microRNA 183.

Authors:  Guorong Li; Coralia Luna; Jianming Qiu; David L Epstein; Pedro Gonzalez
Journal:  J Biol Chem       Date:  2009-11-24       Impact factor: 5.157

Review 9.  Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis.

Authors:  Ming Luo; Jun-Lin Guan
Journal:  Cancer Lett       Date:  2009-07-29       Impact factor: 8.679

Review 10.  Metastasis review: from bench to bedside.

Authors:  Ali Mohammad Alizadeh; Sadaf Shiri; Sadaf Farsinejad
Journal:  Tumour Biol       Date:  2014-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.